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Introduction 
Sudden cardiac arrest is a severe condition in which the heart stops beating suddenly and 
unexpectedly and often leads to sudden cardiac death outside of the hospital or in the emergency 
room.1 Unexpected sudden cardiac death is rare, with an estimated incidence ranging from 50 to 
100 per 100,000 individuals per year in Europe and North America.2,3 Acute ventricular 
arrhythmia may account for over 80% of sudden cardiac deaths.4  
Retrospective pharmacoepidemiologic studies are used to assess risks attributed to drug 
exposures.5,6 Even though the relationship between QT interval prolongation and sudden cardiac 
death and/or ventricular arrhythmias (SCD/VA) remains putative, drug-induced QT interval 
prolongation may increase the risk of SCD/VA and therefore affects the safety profile of 
medications, which can result in black box warnings and drug withdrawals.7,8 Terfenadine and 
cisapride were withdrawn in the United States (US) in 1998 and 2000 respectively, due to their 
association with QT prolongation and ventricular arrhythmia.9,10 More recently, in 2013, 
azithromycin received a black box warning for potential risk of QT prolongation and fatal 
cardiac arrhythmias based on the findings of a large retrospective pharmacoepidemiologic 
study.11,12  
In this era of big data, particularly for studies of rare outcomes, such as SCD/VA, a valid 
operational definition of the outcome is needed. Physician review of an electrocardiogram (ECG) 
is the gold standard for identifying QT prolongation, however it has limited use in retrospective 
database studies.13 First, ECG results are often not available in administrative databases. Further, 
a study identifying events by manual medical record review of ECGs and physician notes would 
likely be under-powered to quantify the exposure-outcome relationship. Lastly, ECG results are 
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not available for cardiac events which occurred outside of the hospital, and would result in 
underestimation of these events.  
A number of retrospective pharmacoepidemiologic drug safety studies have sought to 
quantify the association between these rare outcomes and different medication exposures, 
however the algorithms identifying SCD/VA have varied between studies.14-18 Further the 
performance of these varying algorithms has not been compared. The objective of this systematic 
literature review was to identify the operational definitions of ventricular arrhythmias and sudden 
cardiac death used in retrospective database studies and compare validation results between 
algorithms.  
Methods 
A systematic literature review in the PubMed electronic databases was conducted to 
identify retrospective studies from peer-reviewed journals. A pre-determined search strategy 
developed by researchers from the US Food and Drug Administration (FDA) Sentinel Initiative 
(Supplemental Table 1) was used to select qualifying studies published between January 1, 2000 
and August 31, 2016.19 The FDA Sentinel Initiative has sought to improve the surveillance of 
safety events related to marketed medications, through the creation of robust databases and 
improved monitoring methods.20 This literature review was limited to studies in humans and 
published in English. Other inclusion criteria were: retrospective studies in administrative 
databases; studies that identified SCD/VA; studies that specified codes for SCD/VA. Titles and 
abstracts of studies identified by the search were screened against the inclusion criteria. Qualifying 
or uncertain studies from title and abstract review underwent further full-text review for selection. 
References of selected studies were also examined for inclusion. Data extracted included 
operational definitions and administrative codes used for identifying SCD/VA. Other aspects of 
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study design including publication year, study setting and population, and sample size, were also 
collected. Validation methods and results were also extracted where validation was conducted. 
This literature review was conducted according to the standards set forth in the Preferred Reporting 
Items for Systematic reviews and Meta-Analyses (PRISMA) statement.21 
Results 
The search strategy identified 1,237 studies. After title and abstract review, 57 studies were 
selected for full-text review, after which, 22 (39%) studies were selected for inclusion. Figure 1 
shows the literature search, review, and selection process.  
[Insert Figure 1] 
Table 1 describes the characteristics of the included studies. More than half of the included 
studies were published after 2012, which was the year a previous literature review of validated 
methods for identifying SCD/VA was published.19 Twelve of the included studies (55%) were 
conducted in US populations, using Medicare or Medicaid data (n=10, 45%),10,11,14,15,22-27 
commercial health plan data (n=1, 5%),18 or Veterans Health Administration data (n=1, 5%).17 The 
other ten studies (45%) were conducted in: European databases (n=5, 23%) from the Netherlands,28 
France,29 Italy,30 Denmark,31 and Sweden32; the Taiwanese National Health Insurance Research 
Database (n=3, 14%)16,33,34; and Canadian provincial databases (n=2, 9%).35,36 International 
Classification of Diseases, Ninth Revision (ICD-9) codes were used in 17 studies (77%), while 4 
studies (18%) used International Classification of Diseases, Tenth Revision (ICD-10) codes, and 
one study (5%) used both ICD-9 and ICD-10 codes. All studies used diagnosis codes for event 
definitions and no procedure codes were used.   
 [Insert Table 1.] 
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Algorithms applied to medical data 
SCD/VA was identified from medical data in 15 studies (68.2%) using ICD-9 and 3 (14%) 
studies using ICD-10. Shared by six ICD-9 medical data studies, the most frequently adopted 
algorithm (Table 2) included diagnosis codes identified from inpatient discharges and emergency 
department (ED) visits.10,15,23,24,27,30 Validation was conducted in 3 of these studies by confirmation 
of SCD/VA through medical record review. When principal inpatient discharge diagnosis and first-
listed ED visit diagnosis were assessed together, the PPVs ranged from 73% to 100%.10,15,30 
Considering both principal and non-principal inpatient discharge diagnoses, the algorithm was 
found to have a 92% positive predictive value (PPV) for identifying SCD/VA in one study.10 
Another study identified a higher PPV with principal ED visit diagnosis (94%) than with principal 
discharge diagnosis (80%).15 
[Insert Table 2.] 
Variations of this algorithm have also been used in several studies. One variation of the 
algorithm (excluded ICD-9 code 798) was used in a Taiwanese study (National Health Insurance 
Research Database) and a Medicaid/HealthCore study but neither study evaluated the validation 
of the algorithm.26,33 Another variation (only included ICD-9 codes 427.1, 427.4, and 427.5) of 
this algorithm identified ventricular arrhythmias from principal inpatient discharge diagnoses 
using Medicare data.22 This study validated the reduced algorithm in a registry cohort of confirmed 
life-threatening ventricular arrhythmia cases, resulting in a sensitivity of 77% and specificity of 
94%. This algorithm also demonstrated a PPV of 93% as validated by medical record review of 
30 cases.22 A third variation (with additional ICD-9 code 427.69) identified SCD/VA from 
inpatient hospitalizations in the Netherlands. Medical record review demonstrated a PPV of 82%. 
Addition of codes for unspecified cardiac arrhythmia codes lowered the PPV to 50%.22,28 
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  The next most common algorithm for arrhythmias was utilized in two studies, one from 
the Netherlands and the other from Canada.28,36 The algorithm identified ventricular arrhythmias 
and cardiac arrest from hospital stays with primary diagnoses of arrhythmias. Only the Dutch study 
validated the algorithm, where a review of medical records was used to verify the ICD-9 codes 
used for ventricular arrhythmia and cardiac arrest (PPV 82%) and ICD-9 codes for unspecified 
cardiac arrhythmias (PPV 10%).28 The five other studies each used a different algorithm to identify 
SCD/VA. The Harvard community health plan study used select ICD-9 subcodes under 426, 427, 
429, 780, and 785 from hospital stays and ED visits, with a low PPV of 4%.18 The United 
Healthcare study included office visits and inpatient stays with diagnoses of arrhythmic events 
(ICD-9 codes 426.x, 427.x) but this approach also had low a PPV of 10% based on a review of 
medical records.9 Three other algorithms were used in two of the Taiwanese studies and the 
Veterans Health Administration study and none of these studies validated their operational 
definition.16,17,34  
 ICD-10 diagnosis codes for acute ventricular arrhythmia were used in 3 studies (13.6%). 
A French study,29 a Denmark-Sweden bi-national study,32 and one of the Canadian studies35 each 
used a different algorithm for identifying QT prolongation in hospital stays or ED visits. The 
Canadian study used ICD-10 codes I47.2 and I49.0 and a manual chart review was conducted in 
202 charts resulting in a PPV of 92%.35 The French study used ICD-10 codes I46.1, I47.2, and 
I49.0 from hospital discharge summaries. In comparison with ECG records, this algorithm had a 
PPV of 60%.29 The bi-national study used ICD-10 codes I47.2, I49.0, I49.3, I46.0, I46.1, I46.9, 
R96.0, and R96.1 and no validation was conducted.32  
 
Algorithms applied to death data 
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Five of the included studies (23%) utilized death certificate or death registry data to identify 
SCD (ICD-9, n=3; ICD-10, n=1; ICD-9 and ICD-10, n=1). Three of four ICD-9 death data studies 
(75%) implemented the same algorithm to define plausible SCD, which excluded deaths with 
terminal institutional stays or terminal procedures inconsistent with unresuscitated cardiac arrest 
(Table 3).14 This algorithm was validated by medical record review in a general Medicaid 
population and in opioid users, and the PPV of this algorithm was 87% and 88%, respectively.14,25  
[Insert Table 3.] 
Another algorithm conducted with Taiwanese death registry data defined the study 
outcome as unspecific cardiovascular death (ICD-9 codes 401-449 and ICD-10 codes I10-I79).16 
The Danish death registry study identified death from cardiovascular causes using ICD-10 codes.31 
Codes used in the Danish study were I00-I99 (diseases of the circulatory system) and R96.x (other 
sudden death, cause unknown).31 Neither study performed validation of their algorithms. 
Discussion 
We identified validated operational definitions for identifying ventricular arrhythmias and 
sudden cardiac death in retrospective database studies. The most frequently used algorithms in 
medical data (Table 2) and death registries (Table 3) had an average PPV of 85% and 88%, 
respectively. These two algorithms were validated in various patient populations, including 
Medicaid and Medicare, administrative claims databases, and several European and Canadian 
databases. For ICD-9 algorithms in medical data, the PPV was highest when limited to principal 
inpatient or ED discharge diagnoses, and addition of less specific subcodes decreased the PPV.9,10 
Though one ICD-10 algorithm in medical data was found to have a high PPV, this algorithm has 
not been used or validated in another database.35 Less than a quarter of the included studies 
identified SCD from death certificates or death registries, however one algorithm using ICD-9 
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codes was found to have a high PPV for identifying sudden cardiac death among patients with a 
low risk of unexpected death.14  
Our study has a few limitations. Firstly, the literature search terms might miss some other 
studies that also identified ventricular arrhythmias and sudden cardiac death in retrospective 
databases. We attempted to address this limitation by examining the references of reviewed studies 
for additional studies and found no additional eligible studies in the references. Secondly, the true 
incidence of ventricular arrhythmias and sudden cardiac death are unknown, since such events 
may originate in the outpatient setting and therefore the diagnosis may not be recorded in medical 
data or may be absent as a cause of death. Hence the incidence and prevalence are likely to be 
underestimated. As such, validation studies usually only calculate the PPV but not sensitivity or 
specificity. However, as a PPV is the proportion of true positive in tested positive, validated 
algorithms with high PPV may accurately identify cases captured in retrospective administrative 
databases.  
 
Conclusions 
Our study identified a validated algorithm for ventricular arrhythmias and sudden cardiac 
death in medical data, as well as a validated operational definition for sudden cardiac death in 
death data. Consistency between studies is necessary for establishing causal relationships between 
medications and rare adverse events, such as ventricular arrhythmias and sudden cardiac death. 
Further, transparency in the reporting of these algorithms is essential for understanding differences 
between studies and should include lists of codes and sufficient data source details (primary versus 
secondary diagnosis, hospitalizations versus ED visits). As such, to ensure comparability between 
new research and the existing literature, pharmacoepidemiologic research in this area should utilize 
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common, validated algorithms, such as the ones identified in our review, to operationally define 
these events.  
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Table 1 Characteristics of reviewed retrospective administrative database studies 
 
First 
author  
Publis
h 
year 
Populatio
n 
Design and sample 
size 
Outcome definition and codes 
utilized 
Code 
versio
n 
Clinical setting 
from which events 
were assessed 
Validation method 
and result 
1 Hanrahan
18 
(PMID: 
7606309) 
1995 US 
Harvard 
Communit
y Health 
Plan 
claims,  
1988-
1990 
Cohort study in 
antihistamine users 
(N=26,320). 
Number of events 
in hospitalization or 
ED not clarified. 
 
Validation: medical 
records review 
(N=1,749) 
Study outcome included 
sudden death, torsades de 
pointes or other ventricular 
arrhythmias, syncope, and 
ventricular ectopy in the 
following settings: 
 (i) Ambulatory events (no 
codes provided); 
(ii) Any hospitalization or ED 
discharge diagnoses of:  
ICD-9 codes 426.0-426.5 
(except 426.2), 427.1, 427.4-
427.6, 427.9, 429.2, 429.9, 
780.2-780.4, 785.0, 785.1, 
785.5;  
(iii) Fatal vital status (no codes 
provided); 
(iv) Electrocardiogram review 
ICD-9 Inpatient and 
outpatient events, 
algorithm applied 
to inpatient events 
only 
Medical records 
review confirmed 
70 events, PPV 4% 
(70/1749)  
2 McDonal
d22 
(PMID: 
1222877
7)  
2002 US 
Medicare 
claims, 
1985-
1995 
 
Descriptive study 
among Medicare 
patients with 
ventricular 
arrhythmia in 
Seattle-area 
Myocardial 
Infarction and 
Triage Intervention 
(MITI) registry 
(N=4,073) 
 
Principal hospitalization 
discharge diagnosis of 
ventricular tachycardia or 
ventricular fibrillation/cardiac 
arrest: 
ICD-9 codes 427.1, 427.4, 
427.5 
 
ICD-9 
 
Inpatient events MITI validation: 
sensitivity 77% and 
specificity 94% (no 
number provided) 
 
KPNC validation: 
PPV 93% 
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Validation: medical 
records review: 
(i) Sensitivity and 
specificity 
calculated using 
MITI data as “gold 
standard” for life-
threatening 
ventricular 
arrhythmias; 
(ii) Clinical chart 
review from Kaiser 
Permanente in 
Northern California 
(KPNC) hospitals 
on all patients 
meeting case  
definition (N=512) 
3 De 
Bruin28   
(PMID: 
1629147
9) 
2005 The 
Netherlan
ds, 
PHARMO 
database, 
1999-
2000 
PHARMO record 
linkage system of a 
defined population 
of 330,000 Dutch 
residents 
 
Validation: medical 
records review 
(N=111) 
Principal hospitalization 
discharge diagnoses of: 
(i) ventricular arrhythmias: 
ICD-9 codes 427.1, 472.4, 
427.41, 427.42, 427.5, 427.69; 
(ii) cases in (i) and unspecified 
cardiac arrhythmias: 
ICD-9 codes 427.2, 427.60, 
427.8, 427.89, 427.9  
ICD-9 
 
 
Inpatient events Medical records 
review  
definition (i): 50 
cases out of 61 
confirmed, PPV 
82%; 
definition (ii): 55 
cases out of 
111confirmed, PPV 
50%  
4 Hennessy
10 
(PMID: 
1866228
8) 
2008 US 
Medicaid 
claims, 
1999-
2000 
Etiologic study of 
7,395 users of 
cisapride, 
metoclopramide, or 
a proton pump 
inhibitor  (N=145 
cases, N=7250 
controls) 
Principal hospitalization 
discharge diagnosis of sudden 
cardiac death or ventricular 
arrhythmia 
ICD-9 codes 427.1, 427.4, 
427.41, 427.42, 427.5, 798, 
798.1, 798.2 
 
ICD-9 Inpatient events Validation 
definition (a 
witnessed sudden 
collapse with the 
person found 
unconscious or 
dead, with evidence 
that the person had 
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The outcome 
validation 
component 
obtained and 
reviewed primary 
medical records for 
N=128 persons 
 
been alive in the 
preceding 24 h, or 
evidenced cardiac 
arrest or ventricular 
arrhythmia in 
medical record) met 
in 118 of the 128 
records, PPV 92%, 
95% CI 86%-96%  
5 Molokhia
29 
(PMID:  
1863788
8)  
2008 France, 
Midi-
Pyrenees 
hospital 
record,  
1999-
2004 
Descriptive study 
for events identified 
from four hospitals 
in the 
administrative area 
of Midi-Pyrenees 
with a population 
coverage of 
614,000 (N=861) 
 
Validation: medical 
records review 
(N=40) 
Hospital discharge summaries 
with diagnosis of ventricular 
tachycardia, ventricular 
fibrillation, or sudden cardiac 
death (claim position 
unspecified): 
ICD-10 codes I47.2, I49.0, 
I46.1 
ICD-
10 
Inpatient events ECG confirmed 24 
out of 40 identified 
cases, PPV 60% 
6 Zambon30 
(PMID: 
1923612
2) 
2009 Italy, 
National 
Health 
Service 
Database,  
1998-
2003 
Case-control study, 
1,275 cases 
identified 
 
Validation: medical 
records review 
(N=11) 
Principal hospitalization 
discharge diagnoses of 
ventricular arrhythmia or 
cardiac arrest: 
ICD-9 codes 427.1, 427.4, 
427.41, 427.42, 427.5, 798, 
798.1, 798.2 
ICD-9 
 
Inpatient events Previous validated 
by medical record 
review in a 
different population 
(N=11).  
8 of 11 identified 
cases confirmed: 1 
out of 4 cases of 
ventricular 
arrhythmias and 7 
out of 7 cases of 
cardiac arrest; PPV 
73% 
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7 Chung14  
(PMID: 
2002982
3) 
2010 US 
Medicaid 
claims, 
1990-
1993 
Validation study in 
events identified in 
TN Medicaid 
population  
(N=926) 
 
Validation: medical 
records review 
(N=174) 
Sudden cardiac death in death 
certificate while having no 
evidence of a terminal 
institutional stay or no 
terminal procedures 
inconsistent with 
unresuscitated cardiac arrest:  
ICD-9 codes 401.9, 402.9, 
410, 411, 414.0, 414.8, 414.9, 
425.4, 427.1, 427.4, 427.5, 
427.9, 429.2, 429.9, 440.9, 
798.9 
(ICD-10 codes not provided) 
ICD-9 Inpatient and 
outpatient events 
151 of 174 
identified cases 
confirmed, PPV 
87%; 
PPV for deaths 
occurring between 
1994–1998 (ICD-9 
coding): 85.1%;  
PPV for deaths 
between 1999– 
2005 (ICD-10 
coding): 87.4% 
8 Hennessy
15 
(PMID:  
1984494
5)  
2010 US 
Medicaid 
and 
Medicare 
claims, 
1999–
2002 
Validation study, 
events identified in 
inpatient settings 
(N=5,239) and ED 
visits (N=29,135) 
 
Validation: medical 
records review 
(N=116)  
Primary hospitalization 
discharge diagnoses or first-
listed ED visit diagnosis of 
sudden cardiac death or 
ventricular arrhythmia:  
ICD-9 codes 427.1, 427.4, 
427.41, 427.42, 427.5, 798, 
798.1, 798.2 
ICD-9 
 
Inpatient events Medical record 
review of randomly 
selected patients in 
the cohort validated 
99 out of 116 cases 
identified, PPV 
85%, 95% CI 78%–
91% 
 
Principal 
hospitalization 
discharge 
diagnosis: PPV 
80%, 95% CI 68%-
88%;  
First-listed ED 
visits diagnosis: 
PPV 94%, 95% CI 
83%-98% 
9 Johannes3
6 
2010 Canada, 
Saskatche
wan 
Health,  
Nested case-control 
study in a cohort of 
domperidone or PPI 
users (N=83,212); 
Primary hospitalization 
discharge diagnoses of 
ventricular arrhythmias: 
ICD-9 Inpatient events No independent 
validation 
conducted; case 
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(PMID: 
2065286
2) 
1990-
2005 
1,608 cases 
identified 
 
Validation: none 
ICD-9 codes 427.1, 472.4, 
427.41, 427.42, 427.5, 427.69;  
 
definition cited to 
have PPV of 82%  
1
0 
Leonard23  
(PMID: 
2179671
8) 
2011 US 
Medicaid 
claims, 
1999–
2003 
Cohort study in 
antidepressants 
users 
(N=3,397,470); 
4,222 events 
identified 
 
Validation: none 
Primary hospitalization 
discharge diagnoses or first-
listed ED visit diagnosis of 
sudden cardiac death or 
ventricular arrhythmia:  
ICD-9: 427.1, 427.4, 427.41, 
427.42, 427.5, 798, 798.1, 
798.2 
ICD-9 Inpatient events No independent 
validation 
conducted; outcome 
definition cited to 
have PPV of 85% 
1
1 
Kawai25 
(PMID: 
2293853
1) 
2012 US 
Medicaid 
claims, 
1992-
2007 
Validation study of 
737 events 
identified in a 
cohort of 
propoxyphene or 
hydrocodone users 
(N=453,836) 
 
Validation: medical 
records review 
(N=81)  
Sudden cardiac death in death 
certificate in a community 
setting while having no 
evidence of a terminal 
institutional stay or no 
terminal procedures 
inconsistent with 
unresuscitated cardiac arrest,  
ICD-9 codes 401.9, 402.9, 
410, 411, 414.0, 414.8, 414.9, 
425.4, 427.1, 427.4, 427.5, 
427.9, 429.2, 429.9, 440.9, 
798.9 
ICD-9 Inpatient and 
outpatient events 
Medical records 
review of the 81 
sudden cardiac 
deaths identified 
confirmed 71 in the 
opioid user 
population, 
PPV=88%  
1
2 
Ray11 
(PMID: 
2259129
4) 
2012 US 
Medicaid 
claims, 
1992-
2006 
Cohort study of 
azithromycin 
episodes 
(N=347,795); 29 
cardiovascular 
deaths identified 
 
Validation: none 
 
Cardiovascular death and 
sudden cardiac death in death 
certificate while having no 
evidence of a terminal 
institutional stay or no 
terminal procedures 
inconsistent with 
unresuscitated cardiac arrest,  
ICD-9 codes 401.9, 402.9, 
410, 411, 414.0, 414.8, 414.9, 
425.4, 427.1, 427.4, 427.5, 
ICD-9 Inpatient and 
outpatient events 
No independent 
validation 
conducted; 
outcomes definition 
cited to have PPV 
of 87% 
15 
 
427.9, 429.2, 429.9, 440.9, 
798.9 
1
3 
Schellem
an26 
(PMID: 
2231879
5) 
2012 US 
Medicaid 
claims, 
1999-
2003; 
HealthCor
e 
Database,  
2001-
2006 
Cohort study of 
new 
methylphenidate 
users (N=43,999); 
54 events identified  
 
Validation: none 
Primary hospitalization 
discharge diagnoses or first-
listed ED visit diagnosis of 
sudden cardiac death or 
ventricular arrhythmia:  
ICD-9 codes 427.1, 427.4, 
427.41, 427.42, 427.5, 798.1, 
798.2 
ICD-9 Inpatient events No independent 
validation 
conducted 
1
4 
Leonard24 
(PMID: 
2402765
5)  
2013 US 
Medicaid 
claims,  
1999–
2003 
Cohort study of 
incident 
antipsychotic users 
(N=459,614); 747 
events identified 
  
Validation: none 
Primary hospitalization 
discharge diagnoses or first-
listed ED visit diagnosis of 
sudden cardiac death or 
ventricular arrhythmia:  
ICD-9 codes 427.1, 427.4, 
427.41, 427.42, 427.5, 798, 
798.1, 798.2 
ICD-9 Inpatient events No independent 
validation study 
conducted; outcome 
definition cited to 
have PPV of 85% 
1
5 
Svanstro
m31 
(PMID: 
2363505
0) 
2013 Denmark 
and 
Danish,  
Civil 
Registrati
on 
System, 
1997-
2010 
Cohort study of 
azithromycin 
episodes 
(N=1,102,419); 17 
events identified 
 
Validation: none 
Death from cardiovascular 
causes obtained from the 
Danish Register of Causes of 
Death: 
ICD-10 codes I00-99, R96.0, 
R96.1 
ICD-
10 
 
Inpatient and 
outpatient events 
No independent 
validation 
conducted 
1
6 
Leonard27 
(PMID: 
2502951
9) 
2014 US 
Medicaid 
claims,  
1999–
2007 
Cohort study in 
loop diuretics users 
(N=654,060); 1,470 
events identified 
 
Validation: none 
Primary hospitalization 
discharge diagnoses or first-
listed ED visit diagnosis of 
sudden cardiac death or 
ventricular arrhythmia:  
ICD-9 
 
Inpatient events No independent 
validation 
conducted; outcome 
definition cited to 
have PPV of 85% 
16 
 
ICD-9 codes 427.1, 427.4, 
427.41, 427.42, 427.5, 798, 
798.1, 798.2 
1
7 
Rao17 
(PMID: 
2461530
7) 
2014 US 
Veterans 
Health 
Administr
ation 
Database, 
1999-
2012 
Cohort study of 
azithromycin 
episodes 
(N=594,792); 
number of events 
not specified 
 
Validation: none 
Any hospitalization discharge 
diagnoses or first-listed ED 
visit diagnosis of serious 
cardiac arrhythmia:  
ICD-9 codes 426.82, 427.0, 
427.1, 427.2, 427.41, 427.42, 
427.5 
ICD-9 
 
Inpatient events No independent 
validation 
conducted 
1
8 
Chen34 
(PMID: 
2609841
0) 
2015 Taiwan, 
National 
Health 
Insurance 
Research 
Database 
(NHIRD),  
2000-
2011 
Case-crossover 
study in general 
population of 
NHIRD; 25,356 
cases of 
arrhythmias 
identified 
 
Validation: none 
Hospitalization or ER visit 
with a 
principal diagnosis of cardiac 
dysrhythmias: 
ICD-9 codes 427.x, 798.x 
 
ICD-9 Inpatient events No independent 
validation 
conducted 
1
9 
Chou16 
(PMID: 
2540947
6) 
2015 Taiwan,  
NHIRD,  
2001-
2011 
Cohort study in 
azithromycin, 
clarithromycin, 
moxifloxacin, 
levofloxacin, 
ciprofloxacin, or 
amoxicillin-
clavulanate users 
(N=10,684,100); 
275 events of 
severe ventricular 
arrhythmia and 279 
cardiovascular 
deaths identified 
 
Validation: none 
Any inpatient or outpatient 
(including ED visit) diagnosis 
of severe ventricular 
arrhythmia (diagnosis type 
unspecified): 
ICD-9 codes 427.1, 427.4, 
427.5, 798.1, 798.2, 798.9, 
V12.53; 
 
Cardiovascular death 
identified in death registry: 
ICD-9 codes 401–449 
ICD-10 codes I10–I79 
ICD-9 
and 
ICD-
10 
 
Inpatient and 
outpatient events 
No independent 
validation 
conducted 
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2
0 
Wu33 
(PMID: 
2571329
4) 
2015 Taiwan,  
NHIRD,  
2000-
2009 
Case-crossover 
study in general 
population of 
NHIRD; 17,718 
incident cases 
identified 
 
Validation: none 
Primary hospitalization 
discharge diagnoses or first-
listed ED visit diagnosis of 
sudden cardiac death or 
ventricular arrhythmia:  
ICD-9 codes 427.1, 427.4, 
427.41, 427.42, 427.5, 798.1, 
798.2 
ICD-9 Inpatient events No independent 
validation 
conducted 
2
1 
Inghamm
ar32 
(PMID: 
2692066
6) 
2016 Denmark 
and 
Sweden,  
National 
healthcare 
registry,  
Denmark: 
1997-
2011; 
Sweden: 
2006-
2013 
Cohort study of 
fluoroquinolone 
episodes 
(N=909,656); 66 
events identified 
 
Validation: none  
Primary hospitalization 
discharge diagnoses or first-
listed ED visit diagnosis of 
fatal or non-fatal serious 
arrhythmia: 
ICD-10 codes I47.2, I49.0, 
I49.3, I46.0, I46.1, I46.9, 
R96.0, R96.1 
ICD-
10 
Inpatient events No independent 
validation 
conducted 
2
2 
Trac35 
(PMID: 
2690335
9) 
2016 Canada, 
Ontario 
Health 
Insurance 
Plan, 
2002-
2013 
Cohort study in 
macrolide users 
(N= 616,359) with 
260 events  
 
Validation: medical 
records review 
(N=202) 
Any hospitalization discharge 
diagnoses or ED visit 
diagnosis of ventricular 
arrhythmia: 
ICD-10 codes I47.2, I49.0  
ICD-
10 
Inpatient events PPV 92%, 95% CI 
87%–95% 
CI = confidence interval; ED = emergency department; ICD = International Classification of Diseases; NDI = National Death Index; NPV = 
negative predictive value; PPV = positive predictive value; SCA = sudden cardiac arrest; SCD = sudden cardiac death; TNR = true negative rate; 
TPR = true positive rate; US = United States; VA = ventricular arrhythmias 
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Table 2. Algorithm for identifying ventricular arrhythmia and sudden cardiac death in medical 
data* 
ICD-9 code+ Code description 
427.1 Paroxysmal ventricular tachycardia 
427.4 Ventricular fibrillation and flutter 
427.41 Ventricular fibrillation 
427.42 Ventricular flutter 
427.5 Cardiac arrest 
427.9 Cardiac dysrhythmia, not otherwise specified 
798 Sudden death, cause unknown 
798.1 Instantaneous death 
798.2 Death occurring in less than 24 hours from onset of symptoms, not otherwise 
explained 
ED = Emergency Department; ICD = International Classification of Diseases 
 
* Algorithm used by 6 of the included studies10,15,23,24,27,30 
+ Variations of this algorithm were used in 4 other studies22,26,28,33 
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Table 3.  
Algorithm for identifying ventricular arrhythmia and sudden cardiac death in death data * 
ICD-9 code Code description 
401.9 Essential hypertension, not otherwise specified 
402.9 Hypertensive heart disease, not otherwise specified 
410 Myocardial infarction 
411 Other acute/subacute ischemic heart disease 
414.0 Coronary atherosclerosis 
414.8 Chronic ischemic heart disease, other 
414.9 Chronic ischemic heart disease, unspecified 
425.4 Primary cardiomyopathy, not otherwise specified 
427.1 Paroxysmal ventricular tachycardia 
427.4 Ventricular fibrillation and flutter 
427.5 Cardiac arrest 
427.9 Cardiac dysrhythmia, not otherwise specified 
429.2 Cardiovascular arteriosclerosis  
429.9 Cardiovascular disease, not otherwise specified 
440.9 Atherosclerosis, generalized and unspecified 
798.9 Unattended death 
ICD = International Classification of Diseases 
* Algorithm used by 3 of the included studies11,14,25 
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Figure1.  
Flow chart of literature search and selection process 
ECG = electrocardiogram, QTc = corrected QT interval 
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